A digital view of the world illustrates how Astellas is a global company committed to serving patients worldwide.

News

Astellas is committed to providing timely and accurate information about our business, science and products. This section offers global resources for investors, journalists and media professionals. News and resources from our local affiliates can be viewed in the Local news section. If you are not an investor or journalist, click here.

Month Year

Nov 10, 2009

Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide

Read more
Nov 6, 2009

Theravance and Astellas Announce the Commercial Launch of VIBATIV™ (telavancin) in the United States

Read more
Nov 5, 2009

Transfer of Fermentation and Biotechnology Labs.

Tokyo, Japan, November 5, 2009 -Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced today that it has decided to transfer the functions of...

Read more
Nov 5, 2009

Astellas Announces Acquisition of Treasury Stock

(Acquisition of treasury stock pursuant to the provision of its Articles of Incorporation in accordance with Article 165, paragraph 2 of the Companies Act)

Japan, November 5, 2009 – Astellas Pharma Inc. (Headquarters: Tokyo; President and CEO: Masafumi Nogimori, hereinafter called the “the Company”) announced that at the meeting of the Board of...

Read more
Oct 28, 2009

Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections in Europe

Read more

Show per page

Discover more

Media contacts

Return to media homepage

Subscribe to news alerts

Su	Mo	Tu	We	Th	Fr	Sa

Su	Mo	Tu	We	Th	Fr	Sa

Choose Language

News